Nxera Pharma Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-12,530	-4,662	-10,680	1,078	433
Depreciation & Amortization	4,366	3,984	2,478	1,345	1,278
Loss (Gain) From Sale of Assets	-	-	-	-	3,138
Asset Writedown & Restructuring Costs	1,160	-	-	-	-
Loss (Gain) From Sale of Investments	-	5	1,363	1,877	-208
Loss (Gain) on Equity Investments	-	-	-	429	-50
Stock-Based Compensation	1,953	-	-	-	-
Other Operating Activities	3,940	28	-942	338	486
Change in Accounts Receivable	-1,039	-742	1,315	-210	-799
Change in Inventory	-2,456	-5,935	1,908	-	-
Change in Accounts Payable	2,971	-487	1,552	315	-184
Change in Unearned Revenue	-1,918	-	-	-	-
Change in Other Net Operating Assets	885	91	-2,267	4,780	3,001
Operating Cash Flow	-2,668	-7,718	-5,273	9,952	7,095
Operating Cash Flow Growth	-	-	-	40.27%	51.86%
Capital Expenditures	-448	-526	-804	-277	-193
Cash Acquisitions	-	-	-62,941	-	-
Divestitures	-	-	-	-	206
Sale (Purchase) of Intangibles	-177	-1,011	-47	-26	-8
Investment in Securities	6,028	-3,870	-	1,209	-
Other Investing Activities	27	644	1	137	273
Investing Cash Flow	5,430	-4,763	-63,791	1,043	278
Long-Term Debt Issued	-	-	71,608	-	29,855
Long-Term Debt Repaid	-16,029	-5,800	-1,450	-	-
Total Debt Repaid	-16,029	-5,800	-1,450	-	-
Net Debt Issued (Repaid)	-16,029	-5,800	70,158	-	29,855
Issuance of Common Stock	-	-	9,983	-	600
Other Financing Activities	1	-1,054	-31,812	-4,887	-19,332
Financing Cash Flow	-16,028	-6,854	48,329	-4,887	11,123
Foreign Exchange Rate Adjustments	1,362	2,538	3,243	362	1,583
Miscellaneous Cash Flow Adjustments	1	-	-	-	-
Net Cash Flow	-11,903	-16,797	-17,492	6,470	20,079
Free Cash Flow	-3,116	-8,244	-6,077	9,675	6,902
Free Cash Flow Growth	-	-	-	40.18%	50.70%
Free Cash Flow Margin	-10.52%	-28.59%	-47.60%	62.14%	38.97%
Free Cash Flow Per Share	-34.52	-91.87	-73.65	117.14	84.17
Cash Interest Paid	531	435	241	171	157
Cash Income Tax Paid	-1,007	269	1,394	262	-87
Levered Free Cash Flow	-4,841	-9,249	-11,530	-1,367	8,544
Unlevered Free Cash Flow	-169.38	-8,768	-11,038	-946.5	8,868
Change in Working Capital	-1,557	-7,073	2,508	4,885	2,018

Source: S&P Global Market Intelligence. Standard template. Financial Sources.